好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | C141 - Rapidly Progressive Dementia

Tuesday 04/16/24
03:30 PM - 05:30 PM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Gregory S. Day, MD, MSc, FAAN
Aging, Dementia, and Behavioral Neurology
Participants should become familiar with the common causes and clinical features of rapidly progressive dementia, be able to apply sensitive and specific tests to accurately diagnose patients with specific causes of rapidly progressive dementia, and be able to recognize the clinical and paraclinical findings that suggest a potentially reversible cause of rapidly progressive dementia.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist
Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
03:30 PM - 04:00 PM MDT Speaker Approach to RPD
Gregory S. Day, MD, MSc, FAAN
04:00 PM - 04:25 PM MDT Speaker Creutzfeldt-Jakob Disease
Valerie Sim, MD, BSc
04:25 PM - 04:50 PM MDT Speaker Recognizing Treatment Responsive Causes of RPD
Gregory S. Day, MD, MSc, FAAN
04:50 PM - 05:20 PM MDT Speaker RPD Cases (Interactive Discussion)
Gregory S. Day, MD, MSc, FAAN, Valerie Sim, MD, BSc
05:20 PM - 05:30 PM MDT Q&A Questions & Answers
Gregory S. Day, MD, MSc, FAAN, Valerie Sim, MD, BSc
Faculty Disclosures
Valerie Sim, MD, BSc The institution of Dr. Sim has received research support from CJD Foundation. The institution of Dr. Sim has received research support from National Research Council of Canada Nanotechnology Research Centre. The institution of Dr. Sim has received research support from Alberta Innovates. The institution of Dr. Sim has received research support from Alzheimer Society of Canada. The institution of Dr. Sim has received research support from ALS Canada / Brain Canada. Dr. Sim has received intellectual property interests from a discovery or technology relating to health care. Dr. Sim has received personal compensation in the range of $500-$4,999 for serving as a Clinical neurology consultant for human prion diseases with Public Health Agency of Canada.
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Parabon Nanolabs. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.